• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由与T细胞或Fc受体多肽融合的CD4激活的针对HIV的细胞免疫。

Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides.

作者信息

Romeo C, Seed B

机构信息

Department of Genetics, Harvard Medical School, Boston, Massachusetts.

出版信息

Cell. 1991 Mar 8;64(5):1037-46. doi: 10.1016/0092-8674(91)90327-u.

DOI:10.1016/0092-8674(91)90327-u
PMID:1900456
Abstract

We describe functional simplified T cell and Fc receptor chimeras that are capable of directing CD8+ cytotoxic T lymphocytes (CTLs) to specifically recognize and lyse cells expressing HIV envelope proteins. Target cells bearing HLA-DR molecules are not recognized by CTL armed with the chimeras. The variety of cell types in which the native receptors are active suggests multiple possibilities for antiviral intervention through genetic means.

摘要

我们描述了功能性简化的T细胞和Fc受体嵌合体,它们能够引导CD8 + 细胞毒性T淋巴细胞(CTL)特异性识别并裂解表达HIV包膜蛋白的细胞。携带HLA-DR分子的靶细胞不会被携带嵌合体的CTL识别。天然受体具有活性的多种细胞类型表明通过基因手段进行抗病毒干预具有多种可能性。

相似文献

1
Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides.由与T细胞或Fc受体多肽融合的CD4激活的针对HIV的细胞免疫。
Cell. 1991 Mar 8;64(5):1037-46. doi: 10.1016/0092-8674(91)90327-u.
2
Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain.介导杀伤任何毒株的人类免疫缺陷病毒感染细胞的双特异性抗体。
Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4723-7. doi: 10.1073/pnas.88.11.4723.
3
Cytotoxic T lymphocyte triggering via CD16 is regulated by CD3 and CD8 antigens. Studies with T cell receptor (TCR)-alpha beta+/CD3+16+ and TCR-gamma delta+/CD3+16+ granular lymphocytes.通过CD16触发的细胞毒性T淋巴细胞受CD3和CD8抗原调节。对T细胞受体(TCR)-αβ+/CD3+16+和TCR-γδ+/CD3+16+颗粒淋巴细胞的研究。
J Immunol. 1990 May 1;144(9):3312-7.
4
High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function.高亲和力的CD8 + T细胞能有效清除活跃的HIV感染靶细胞,并执行局部聚焦的抗病毒功能程序。
PLoS One. 2014 Feb 13;9(2):e87873. doi: 10.1371/journal.pone.0087873. eCollection 2014.
5
Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.抗CD3单克隆抗体加白细胞介素2诱导的人CD4+辅助/杀伤性T细胞的双特异性抗体导向抗肿瘤活性
Jpn J Cancer Res. 1991 Nov;82(11):1207-10. doi: 10.1111/j.1349-7006.1991.tb01782.x.
6
T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.由一种天然的1型人类免疫缺陷病毒(HIV)变异肽诱导的,HIV gp120特异性CD4(+)细胞毒性T细胞克隆的T细胞受体介导的无反应性
J Virol. 2000 Mar;74(5):2121-30. doi: 10.1128/jvi.74.5.2121-2130.2000.
7
CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.CD2/LFA - 3或LFA - 1/ICAM - 1相互作用而非CD28/B7相互作用可增强病毒特异性CD8 + 细胞毒性T淋巴细胞的细胞毒性。
Eur J Immunol. 1993 Feb;23(2):418-24. doi: 10.1002/eji.1830230218.
8
Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted.人类CD8+ T细胞介导的免疫抑制是受体依赖性的且受HLA-DQ限制。
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2598-602. doi: 10.1073/pnas.88.6.2598.
9
Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes.
Nature. 1990 May 17;345(6272):258-60. doi: 10.1038/345258a0.
10
Lysis of cells infected with HIV-1 by human lymphocytes targeted with monoclonal antibody heteroconjugates.用单克隆抗体异源缀合物靶向的人淋巴细胞对感染HIV-1的细胞进行裂解。
J Immunol. 1988 Apr 15;140(8):2609-13.

引用本文的文献

1
Transitioning from native to synthetic receptors: broadening T-cell engineering and beyond.从天然受体到合成受体的转变:拓展T细胞工程及其他领域
Cell Mol Immunol. 2025 Jun 6. doi: 10.1038/s41423-025-01304-8.
2
From concept to cure: The evolution of CAR-T cell therapy.从概念到治愈:嵌合抗原受体T细胞疗法的演变
Mol Ther. 2025 May 7;33(5):2123-2140. doi: 10.1016/j.ymthe.2025.03.005. Epub 2025 Mar 10.
3
Cellular therapies in rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病的细胞疗法。
J Transl Autoimmun. 2024 Dec 16;10:100264. doi: 10.1016/j.jtauto.2024.100264. eCollection 2025 Jun.
4
From TCR fundamental research to innovative chimeric antigen receptor design.从T细胞受体基础研究到创新型嵌合抗原受体设计。
Nat Rev Immunol. 2025 Mar;25(3):212-224. doi: 10.1038/s41577-024-01093-7. Epub 2024 Oct 21.
5
Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti-tumour activity.比较七种 CD19 CAR 设计在工程化 NK 细胞中增强抗肿瘤活性的作用。
Cell Prolif. 2024 Nov;57(11):e13683. doi: 10.1111/cpr.13683. Epub 2024 Jun 3.
6
Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.抗 PD-1 嵌合抗原受体 T 细胞能有效地靶向生发中心中受 SIV 感染的 CD4+ T 细胞。
J Clin Invest. 2024 Apr 1;134(7):e169309. doi: 10.1172/JCI169309.
7
CAR Immunotherapy for the treatment of infectious diseases: a systematic review.嵌合抗原受体免疫疗法治疗感染性疾病:系统评价。
Front Immunol. 2024 Jan 30;15:1289303. doi: 10.3389/fimmu.2024.1289303. eCollection 2024.
8
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity.抗原诱导的嵌合抗原受体多聚化扩增了肿瘤杀伤活性。
Signal Transduct Target Ther. 2023 Dec 8;8(1):445. doi: 10.1038/s41392-023-01686-z.
9
CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond.嵌合抗原受体T细胞疗法治疗多发性骨髓瘤:B细胞成熟抗原(BCMA)及其他。
Vaccines (Basel). 2023 Nov 16;11(11):1721. doi: 10.3390/vaccines11111721.
10
Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure.靶向 HIV 储存库:嵌合抗原受体治疗 HIV 治愈。
Chin Med J (Engl). 2023 Nov 20;136(22):2658-2667. doi: 10.1097/CM9.0000000000002904. Epub 2023 Nov 6.